NASDAQ · Biotechnology

Viking Therapeutics Inc (VKTX)

$33.89 -1.37%

Add alert

48 In band Daily RSI (14) · 21 Aug 2026

Moving averages

SMA 200$33.79+0.30%

Company profile

Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, is focused on developing new therapies for metabolic and endocrine disorders. The company is headquartered in San Diego, California.

SectorHealthcare

IndustryBiotechnology

Market cap$4.02B

P/E ratioNone

EPS$-4.69

Beta0.685

Dividend yield0.00%

52-week high$43.15

52-week low$22.96

Similar stocks in Biotechnology

BNTX BioNTech SE RSI 79 VRTX Vertex Pharmaceuticals Inc RSI 67 CRSP CRISPR Therapeutics AG RSI 67 IOVA Iovance Biotherapeutics Inc RSI 72 MRNA Moderna Inc RSI 72 SRPT Sarepta Therapeutics Inc RSI 59 EDIT Editas Medicine Inc RSI 57 NVAX Novavax Inc RSI 63 DNA Ginkgo Bioworks Holdings Inc - Class A RSI 46 RXRX Recursion Pharmaceuticals Inc - Class A RSI 59

Free forever

RSI alerts for VKTX

Get an email the moment Viking Therapeutics Inc crosses into oversold or overbought territory. Nothing else, ever.

Add alert

Data last updated 12 August 2026 at 7:10 AM EDT